These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27125084)

  • 81. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
    Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
    Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.
    Kuo HK; Chen YH; Huang F; Wu YC; Shiea J; Wu PC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):205-13. PubMed ID: 25940552
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment.
    Hasanpour H; Kenney MC; Kuppermann BD; Esfahani MR; Kanavi MR; Singh MK; Soheilian M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835796
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.
    Troger J; Kremser B; Irschick E; Göttinger W; Kieselbach G
    Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):900-3. PubMed ID: 9865620
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Kininogen 1 and insulin-like growth factor binding protein 6: candidate serum biomarkers of proliferative vitreoretinopathy.
    Yu J; Peng R; Chen H; Cui C; Ba J; Wang F
    Clin Exp Optom; 2014 Jan; 97(1):72-9. PubMed ID: 23808406
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Steroid Drugs as an Adjunct for Reducing the Incidence of Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment Surgery: A Meta-Analysis of Randomized Controlled Studies.
    Xu M; Fan X; Huang X; Chen X; Shao Y; Li X
    Ophthalmic Res; 2023; 66(1):599-610. PubMed ID: 36754031
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Rotsos T; Moschos MM; Souliou E; Dimitrakos SA; Diza E
    Ocul Immunol Inflamm; 2014 Dec; 22(6):449-53. PubMed ID: 24354433
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Level of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal detachment.
    Baba T; Oshitari T; Yamamoto S
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1251-4. PubMed ID: 25311653
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane.
    Pietras-Baczewska A; Nowomiejska K; Brzozowska A; Toro MD; Załuska W; Sztanke M; Sztanke K; Rejdak R
    Life (Basel); 2021 May; 11(5):. PubMed ID: 34069386
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High-speed, high-resolution spectral optical coherence tomography in patients after vitrectomy with internal limiting membrane peeling for proliferative vitreoretinopathy retinal detachment.
    Odrobina DC; Michalewska Z; Michalewski J; Nawrocki J
    Retina; 2010 Jun; 30(6):881-6. PubMed ID: 20182404
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Risk factors for surgical failures in rhegmatogenous retinal detachment].
    Mangouritsas G; Rothbächer HH; Heidenkummer PH; Ulbig MW; Kampik A
    Klin Monbl Augenheilkd; 1995 Jan; 206(1):20-8. PubMed ID: 7897964
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment.
    Yeung L; Yang KJ; Chen TL; Wang NK; Chen YP; Ku WC; Lai CC
    Acta Ophthalmol; 2008 Mar; 86(2):165-9. PubMed ID: 17995984
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Vitreous Chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy.
    Hayasaka S; Zhang XY; Cui HS; Yanagisawa S; Chi ZL; Hayasaka Y; Shimada Y
    Am J Chin Med; 2006; 34(4):537-43. PubMed ID: 16883625
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC
    Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
    Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
    Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment.
    Cederlund M; Ghosh F; Arnér K; Andréasson S; Akerström B
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):725-32. PubMed ID: 22829194
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal Detachment.
    Tsunekawa T; Kaneko H; Takayama K; Hwang SJ; Oishi A; Nagasaka Y; Ye F; Iwase T; Nonobe N; Ueno S; Ito Y; Yasuda S; Matsuura T; Shimizu H; Suzumura A; Kataoka K; Terasaki H
    Biomed Res Int; 2017; 2017():3427319. PubMed ID: 28261609
    [No Abstract]   [Full Text] [Related]  

  • 100. [Vitreous surgery with trypan blue staining of membranes in PVR retinal detachment surgery].
    Nawrocki J; Michalewska Z; Michalewski J
    Klin Monbl Augenheilkd; 2005 Jul; 222(7):572-6. PubMed ID: 16034725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.